Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

Criteo SA is a global technology company, which specializes in digital performance marketing. The firm enables e-commerce companies to leverage large volumes of granular data to engage and convert their customers. It operates through the following segments: Marketing Solutions and Retail Media. The Marketing Solutions segment allows commerce companies to address multiple marketing goals by engaging their consumers with personalized ads across the web, mobile and offline store environments. The Retail Media segment allows retailers to generate advertising revenues from consumer brands, and/or to drive sales for themselves, by monetizing their data and audiences through personalized ads, either on their own digital property or on the open Internet, that address multiple marketing goals. The company was founded by Jean-Baptiste Rudelle, Franck Le Ouay, Pascal Gauthier, Laurent Quatrefages and Romain Niccoli on November 3, 2005 and is headquartered in Paris, France.

Advanced Drainage Systems, Inc. manufactures thermoplastic corrugated pipe, which provides a suite of water management products and drainage solutions for the construction and infrastructure marketplace. It operates through the following segments: Pipe, Infiltrator, International, and Allied Products & Other. The Pipe segment manufactures and markets thermoplastic corrugated pipe throughout the United States. The Infiltrator segment provides plastic leach field chambers and systems, septic tanks and accessories, primarily for use in residential applications. The International segment manufactures and markets pipe and allied products in regions outside of the United States. The Allied Products & Other segment is involved in manufacture and market products throughout the United States. Products include StormTech, Nyloplast, ARC Septic Chambers, Inserta Tee, water quality filters and structures, Fittings, and FleXstorm. The company was founded in 1966 and is headquartered in Hilliard, OH.

Hippo Holdings, Inc. is a home protection company which provides a new standard of care and protection for homeowners. It makes homes safer and better protected so customers spend less time worrying about the burdens of homeownership and more time enjoying their homes. The company harnesses real-time data, smart home technology, and a growing suite of home services to create an integrated home protection platform. It was founded by Assaf Wand on January 10, 2015 and is headquartered in Palo Alto, CA.

Koppers Holdings, Inc. engages in the provision of treated wood products, wood treatment chemicals and carbon compounds. It operates through the following segments: Carbon Materials and Chemicals, Railroad and Utility Products and Services, and Performance Chemicals. The Carbon Materials and Chemicals segment manufactures carbon pitch naphthalene, creosote, and carbon black feedstock. The Railroad and Utility Products and Services segment sells treated and untreated wood products, manufactured products, and services primarily to the railroad and public utility markets. The Performance Chemicals segment includes development, manufacture, and marketing of wood preservation chemicals and wood treatment technologies for use in the pressure treating of lumber for residential, industrial, and agricultural applications. The company was founded in November 2004 and is headquartered in Pittsburgh, PA.

Baker Hughes Co. is a holding company, which engages in the provision of oilfield products, services, and digital solutions. It operates through the Oilfield Services and Equipment (OFSE) and industrial and Energy Technology (IET) segments. The OFSE segment designs and manufactures products and provides services for onshore and offshore oilfield operations. The IET segment combines expertise, technologies, and services for industrial and energy customers including on and off-shore, LNG, pipeline and gas storage, refining, petrochemical, distributed gas, flow and process control, and industrial segments such as nuclear, aviation, automotive, marine, food and beverage, mining, cement and utilities. The company was founded in April 1987 and is headquartered in Houston, TX.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Sezzle, Inc. engages in the operation of a payment platform that enables bank-to-bank transfer of money between consumers and businesses. The company was founded by Charlie Youakim, Killian Brackey and Paul Paradis in 2016 and is headquartered in Minneapolis, MN.

EverCommerce, Inc. engages in providing integrated, vertically-tailored software-as-a-service solutions for service-based small and medium sized businesses. It operates through the United States and International geographical segments. The company was founded by Eric Remer in September 2016 and is headquartered in Denver, CO.

DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients. It also designs a robust clinical development program that includes ongoing clinical trials of Viaskin peanut, and Viaskin milk, as well as pre-clinical development of Viaskin egg. The company was founded by Pierre-Henri Benhamou, Stephane Benhamou, Bertrand Dupont, Christophe Dupont, and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Montrouge, France.